-
ABUS Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Arbutus Biopharma (ABUS)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 31.85 mm | 31.85 mm | 31.85 mm | 31.85 mm | 31.85 mm | 31.85 mm |
Cash burn (monthly) | 10.31 mm | (no burn) | 7.15 mm | 6.93 mm | 6.91 mm | 5.99 mm |
Cash used (since last report) | 41.48 mm | n/a | 28.74 mm | 27.86 mm | 27.80 mm | 24.07 mm |
Cash remaining | -9.64 mm | n/a | 3.10 mm | 3.98 mm | 4.05 mm | 7.77 mm |
Runway (months of cash) | -0.9 | n/a | 0.4 | 0.6 | 0.6 | 1.3 |
13F holders | Current |
---|---|
Total holders | 143 |
Opened positions | 29 |
Closed positions | 15 |
Increased positions | 44 |
Reduced positions | 32 |
13F shares | Current |
---|---|
Total value | 386.13 bn |
Total shares | 139.61 mm |
Total puts | 525.00 k |
Total calls | 2.31 mm |
Total put/call ratio | 0.2 |
Largest owners | Shares | Value |
---|---|---|
ROIV Roivant Sciences | 38.85 mm | $160.83 mm |
MS Morgan Stanley | 21.71 mm | $83.58 bn |
Whitefort Capital Management | 12.87 mm | $49.54 bn |
BlackRock | 12.22 mm | $47.04 bn |
Vanguard | 8.92 mm | $34.34 bn |
Kairos Capital Management | 8.39 mm | $32.29 bn |
STT State Street | 4.41 mm | $16.97 bn |
Geode Capital Management | 3.45 mm | $13.28 bn |
FourWorld Capital Management | 2.97 mm | $11.44 bn |
Adage Capital Partners GP, L.L.C. | 2.90 mm | $11.17 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
14 Aug 24 | Manchester Keith S | Common Shares | Sell | Dispose S | No | No | 3.6895 | 8,846 | 32.64 k | 46,069 |
14 Aug 24 | Manchester Keith S | Common Shares | Option exercise | Acquire M | No | No | 0.56 | 54,915 | 30.75 k | 54,915 |
14 Aug 24 | Manchester Keith S | Stock Option Common Shares | Option exercise | Dispose M | No | No | 0.56 | 54,915 | 30.75 k | 0 |
23 May 24 | Meyers James R | Stock Option Common Shares | Grant | Acquire A | No | No | 3.28 | 67,000 | 219.76 k | 67,000 |
23 May 24 | Manchester Keith S | Stock Option Common Shares | Grant | Acquire A | No | No | 3.28 | 67,000 | 219.76 k | 67,000 |
23 May 24 | Burgess Daniel D | Stock Option Common Shares | Grant | Acquire A | No | No | 3.28 | 67,000 | 219.76 k | 67,000 |
23 May 24 | Henriques Richard C JR | Stock Option Common Shares | Grant | Acquire A | No | No | 3.28 | 67,000 | 219.76 k | 67,000 |